semaglutide injections manhattan NYC Semaglutide Weight Loss Injections &
Description
Gen Zers in our December 2024 survey came across weight loss drug content on social media (55%) more than any other media channel or setting
The conglomerate has a presence across the pharma value chain from manufacturing to diagnostics and medical devices
Check out the full study in Nature and our new GLP-1 report here: / / #Genetics #GLP1 #PrecisionMedicine #Biotech #23andMe #HealthTech
We cover the BMI, health, and medical history requirements for these weight loss medications
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
